We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Population pharmacokinetics and pharmacodynamics of cinaciguat, a soluble guanylate cyclase activator, in patients with acute decompensated heart failure.
- Authors
Mueck, Wolfgang; Frey, Reiner
- Abstract
Cinaciguat (BAY 58-2667) is a novel soluble guanylate cyclase activator in clinical development for the treatment of acute decompensated heart failure (ADHF). In patients with ADHF, intravenously administered cinaciguat results in potent unloading of the heart with arterial vasodilation. The aims of this study were to define the structural pharmacokinetic and pharmacodynamic models of cinaciguat in patients with ADHF, to characterize interindividual variability and to explore the effects of potential covariates.
- Publication
Clinical pharmacokinetics, 2010, Vol 49, Issue 2, p119
- ISSN
1179-1926
- Publication type
Journal Article
- DOI
10.2165/11317590-000000000-00000